In a multicenter randomized trial of 150 children and adolescents, trigeminal nerve stimulation failed to outperform sham ...

Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the ...

NeuroScientific Biopharmaceuticals’ StemSmart cell therapy has delivered real-world promise for those living with chronic ...

The first patient has been dosed in the TROPION-Lung17 phase 3 trial evaluating DATROWAY® (datopotamab deruxtecan) compared ...

The "How to Improve Accuracy and Attention to Detail Training Course (Apr 23, 2026)" training has been added to ResearchAndMarkets.com's offering. Carrying out complex tasks within fast-paced and ...

Guidance is not law, and frameworks should evolve. But the symbolism matters. At a moment when AI is entering clinical ...

Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, ...

Arsenal couldn't beat Nottingham Forest on Saturday but still extended their lead over Manchester City and Aston Villa ...

Biopharmaceutical company Rakuten announced the signing of a manufacturing partnership with contract development and ...

FDA has designated rexlemestrocel-L a Regenerative Medicine Advanced Therapy (RMAT) for the treatment of chronic low back pain. RMAT designation provides all the benefits of Breakthrough and Fast ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

The early-stage results have been described as outstanding. The post Early success in battling Crohn's Disease has sent this ...